Surmodics ROA 2010-2024 | SRDX
Current and historical return on assets (ROA) values for Surmodics (SRDX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Surmodics ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-03-31 | $0.01B | $0.18B | 7.05% |
| 2023-12-31 | $0.01B | $0.18B | 2.77% |
| 2023-09-30 | $-0.00B | $0.19B | -1.13% |
| 2023-06-30 | $-0.02B | $0.19B | -14.06% |
| 2023-03-31 | $-0.04B | $0.17B | -22.09% |
| 2022-12-31 | $-0.03B | $0.17B | -19.19% |
| 2022-09-30 | $-0.03B | $0.16B | -15.93% |
| 2022-06-30 | $-0.01B | $0.18B | -7.03% |
| 2022-03-31 | $-0.01B | $0.18B | -5.40% |
| 2021-12-31 | $0.00B | $0.19B | 1.09% |
| 2021-09-30 | $0.01B | $0.20B | 2.81% |
| 2021-06-30 | $0.00B | $0.18B | 1.16% |
| 2021-03-31 | $0.01B | $0.18B | 4.14% |
| 2020-12-31 | $0.00B | $0.16B | 0.00% |
| 2020-09-30 | $0.00B | $0.17B | 0.00% |
| 2020-06-30 | $0.01B | $0.17B | 4.40% |
| 2020-03-31 | $0.01B | $0.16B | 3.86% |
| 2019-12-31 | $0.01B | $0.16B | 3.90% |
| 2019-09-30 | $0.01B | $0.16B | 4.58% |
| 2019-06-30 | $0.00B | $0.15B | 0.65% |
| 2019-03-31 | $-0.00B | $0.15B | -1.92% |
| 2018-12-31 | $-0.00B | $0.15B | -1.25% |
| 2018-09-30 | $-0.01B | $0.16B | -3.22% |
| 2018-06-30 | $-0.00B | $0.16B | -2.02% |
| 2018-03-31 | $0.00B | $0.16B | 0.71% |
| 2017-12-31 | $0.00B | $0.14B | 0.00% |
| 2017-09-30 | $0.00B | $0.14B | 3.02% |
| 2017-06-30 | $0.01B | $0.13B | 5.33% |
| 2017-03-31 | $0.01B | $0.13B | 7.69% |
| 2016-12-31 | $0.01B | $0.13B | 7.83% |
| 2016-09-30 | $0.01B | $0.13B | 8.91% |
| 2016-06-30 | $0.01B | $0.13B | 7.83% |
| 2016-03-31 | $0.01B | $0.12B | 8.39% |
| 2015-12-31 | $0.01B | $0.11B | 11.06% |
| 2015-09-30 | $0.01B | $0.10B | 12.87% |
| 2015-06-30 | $0.01B | $0.10B | 13.72% |
| 2015-03-31 | $0.01B | $0.09B | 13.54% |
| 2014-12-31 | $0.01B | $0.09B | 12.34% |
| 2014-09-30 | $0.01B | $0.11B | 12.09% |
| 2014-06-30 | $0.01B | $0.10B | 14.21% |
| 2014-03-31 | $0.01B | $0.10B | 13.10% |
| 2013-12-31 | $0.02B | $0.10B | 14.67% |
| 2013-09-30 | $0.02B | $0.10B | 14.22% |
| 2013-06-30 | $0.01B | $0.10B | 13.21% |
| 2013-03-31 | $0.01B | $0.11B | 11.72% |
| 2012-12-31 | $0.01B | $0.11B | 9.16% |
| 2012-09-30 | $0.01B | $0.10B | 7.75% |
| 2012-06-30 | $-0.01B | $0.16B | -7.09% |
| 2012-03-31 | $-0.01B | $0.15B | -6.29% |
| 2011-12-31 | $-0.01B | $0.15B | -6.12% |
| 2011-09-30 | $-0.02B | $0.16B | -11.28% |
| 2011-06-30 | $-0.02B | $0.17B | -12.81% |
| 2011-03-31 | $-0.03B | $0.17B | -15.32% |
| 2010-12-31 | $-0.03B | $0.17B | -16.02% |
| 2010-09-30 | $-0.02B | $0.17B | -11.31% |
| 2010-06-30 | $0.00B | $0.19B | 2.11% |
| 2010-03-31 | $0.01B | $0.19B | 4.80% |
| 2009-12-31 | $0.01B | $0.19B | 7.02% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.490B | $0.133B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $180.835B | 23.68 |
| Stryker (SYK) | United States | $127.824B | 30.61 |
| Boston Scientific (BSX) | United States | $110.956B | 35.34 |
| Medtronic (MDT) | Ireland | $109.267B | 15.80 |
| EssilorLuxottica (ESLOY) | France | $102.270B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.874B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.264B | 27.93 |
| ResMed (RMD) | United States | $31.329B | 29.42 |
| Terumo (TRUMY) | Japan | $25.193B | 35.58 |
| Koninklijke Philips (PHG) | Netherlands | $25.055B | 19.41 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.949B | 15.30 |
| Baxter (BAX) | United States | $17.275B | 12.28 |
| Insulet (PODD) | United States | $12.612B | 55.92 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.873B | 0.00 |
| Demant (WILYY) | Denmark | $10.259B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.193B | 26.79 |
| BellRing Brands (BRBR) | United States | $7.612B | 35.80 |
| Lantheus Holdings (LNTH) | United States | $5.422B | 13.51 |
| GN Store Nord (GNNDY) | Denmark | $4.809B | 27.01 |
| Haemonetics (HAE) | United States | $4.491B | 22.20 |
| Perrigo (PRGO) | Ireland | $3.801B | 11.52 |
| Prestige Consumer Healthcare (PBH) | United States | $3.193B | 15.19 |
| Envista Holdings (NVST) | United States | $3.136B | 12.94 |
| Neogen (NEOG) | United States | $2.872B | 27.62 |
| QuidelOrtho (QDEL) | United States | $2.840B | 15.76 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.733B | 0.00 |
| TG Therapeutics (TGTX) | United States | $2.582B | 72.65 |
| ICU Medical (ICUI) | United States | $2.478B | 21.87 |
| Green Thumb Industries (GTBIF) | United States | $2.375B | 47.04 |
| LeMaitre Vascular (LMAT) | United States | $1.790B | 52.47 |
| Agios Pharmaceuticals (AGIO) | United States | $1.788B | 0.00 |
| Warby Parker (WRBY) | United States | $1.710B | 0.00 |
| InMode (INMD) | Israel | $1.552B | 8.25 |
| Verano Holdings (VRNOF) | United States | $1.418B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.341B | 9.97 |
| Owens & Minor (OMI) | United States | $1.341B | 11.69 |
| National Vision Holdings (EYE) | United States | $1.160B | 36.92 |
| AtriCure (ATRC) | United States | $1.104B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.000B | 0.00 |
| Evolus (EOLS) | United States | $0.783B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.773B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.751B | 15.99 |
| Cresco Labs (CRLBF) | United States | $0.660B | 0.00 |
| Quanterix (QTRX) | United States | $0.628B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.605B | 14.22 |
| Valneva SE (VALN) | France | $0.593B | 0.00 |
| PetIQ (PETQ) | United States | $0.589B | 19.04 |
| TerrAscend (TSNDF) | Canada | $0.461B | 0.00 |
| ZimVie (ZIMV) | United States | $0.458B | 39.05 |
| Jin Medical (ZJYL) | China | $0.425B | 0.00 |
| Biote (BTMD) | United States | $0.394B | 9.07 |
| Aurora Cannabis (ACB) | Canada | $0.363B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.359B | 11.55 |
| Cerus (CERS) | United States | $0.340B | 0.00 |
| Zynex (ZYXI) | United States | $0.334B | 45.74 |
| MacroGenics (MGNX) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 27.15 |
| Sanara MedTech (SMTI) | United States | $0.267B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.262B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 14.89 |
| TriSalus Life Sciences (TLSI) | United States | $0.205B | 0.00 |
| Omeros (OMER) | United States | $0.194B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.191B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Veru (VERU) | United States | $0.180B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.167B | 80.00 |
| InterCure (INCR) | Israel | $0.144B | 24.39 |
| FitLife Brands (FTLF) | United States | $0.138B | 19.61 |
| Quipt Home Medical (QIPT) | United States | $0.136B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.122B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 8.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| MariMed (MRMD) | United States | $0.090B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.084B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.078B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.069B | 0.00 |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.049B | 3.17 |
| United-Guardian (UG) | United States | $0.041B | 14.79 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.032B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Agape ATP (ATPC) | $0.021B | 0.00 | |
| Innovative Eyewear (LUCY) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |